{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:59:55Z","timestamp":1776927595182,"version":"3.51.2"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2020,9,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> The development of multidrug-resistant tuberculosis (MDR-TB) poses a considerable\nthreat to tuberculosis control programmes in Nigeria. There is an increase in the prevalence\nof MDR-TB worldwide both among new tuberculosis cases as well as previously-treated ones. There is\nalso a rise in transmission of resistant strains due to an increase in MDR-TB patients largely due to the\npoor drug compliance and the impact of Human immunodeficiency virus infection. Therefore, we intend\nto determine the extent of MDR-TB among attendees of chest clinics in Osun-State, Nigeria.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>The objective of this study was to determine the prevalence of MDR-TB among confirmed\ntuberculosis patients attending chest clinics in Osun-State, Nigeria.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study was conducted among 207 attendees of chest clinics in Osun-State between June,\n2015 and October 15, 2016. Sputum and blood samples of the participants were collected. GeneXpert\ntest was carried out first on the samples for simultaneous identification of MTB and rifampicin resistance.\nSputum samples were cultured on Lowenstein-Jensen (L-J) medium using N-acetyl-Lcysteine-\nsodium hydroxide (NALC-NaOH) decontamination method. Drug susceptibility testing\n(DST) to three first-line drugs was carried out using the proportion DST method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The prevalence of MTB was found to be 27.5% while the prevalence of MDR-TB from the\nfifty-seven isolates was 10.5%. Previously treated and new cases had a prevalence of 7.0% and 3.5%\nMDR-TB, respectively. Seventy (33.8%) participants were positive for HIV infection, out of which\ntwenty-six (12.6%) had co-infection of tuberculosis and HIV. The mono-resistance rates of the three\nfirst-line drugs used were: 5.3% and 8.7% for ethambutol (EMB) and isoniazid (INH), respectively. No\nisolate had mono-resistance (0%) to rifampicin (RIF).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study observed the prevalence of 27.5% MTB and a prevalence of 10.5% MDR-TB\namong the MTB isolates. The prevalence of TB is high in Osun State. MDR-TB prevalence is higher\ncompared with the national estimate of MDR-TB (5.1%) of 2017. Resistant TB is a threat to national\ntuberculosis control and it is recommended that all the facilities be equipped to cater to its diagnosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201021666200226100242","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T14:36:30Z","timestamp":1582727790000},"page":"939-947","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria"],"prefix":"10.2174","volume":"21","author":[{"given":"Gbadebo J.","family":"Oyedeji","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, P.M.B. 4400 Osogbo, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Adeyemo","sequence":"additional","affiliation":[{"name":"Institutsuperiur de Sante Niamey, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Affolabi","family":"Dissou","sequence":"additional","affiliation":[{"name":"Laboratoire de R\u00e9f\u00e9rence des Mycobact\u00e9ries (LRM) Cotonou, Benin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tope","family":"Abiodun","sequence":"additional","affiliation":[{"name":"Nigeria Institute of Medical Research, Yaba, Lagos, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oyebode A.T.","family":"Alli","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Basic Medical Sci-ences, Ladoke Akintola University of Technology, P.M.B. 4400 Osogbo, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2142-6046","authenticated-orcid":true,"given":"Olakunle J.","family":"Onaolapo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, P.M.B. 4400 Osogbo, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-7050","authenticated-orcid":true,"given":"Adejoke Y.","family":"Onaolapo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, P.M.B. 4000 Ogbomoso, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yemisi","family":"Adesiji","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, P.M.B. 4400 Osogbo, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olugbenga A.","family":"Olowe","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, P.M.B. 4400 Osogbo, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12879-017-2211-5","volume":"17","author":"Derseh D.","year":"2017","unstructured":"Derseh D.; Moges F.; Tessema B.; Smear positive pulmonary tuberculosis and associated risk factors among tuberculosis suspects attending spiritual holy water sites in Northwest Ethiopia. BMC Infect Dis 2017,17(1),100","journal-title":"BMC Infect Dis"},{"key":"ref=2","unstructured":"CDC Drug-Resistant TB\/TB\/CDC"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185105","volume":"12","author":"Musa B.M.","year":"2017","unstructured":"Musa B.M.; Adamu A.L.; Galadanci N.A.; Zubayr B.; Odoh C.N.; Aliyu M.H.; Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One 2017,12(9)","journal-title":"PLoS One"},{"key":"ref=4","unstructured":"Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"ref=5","unstructured":"Implementing the End Tb Strategy: The Essentials. World Health\nOrganization, 2015. Retrieved: 12.03.2018. Available at:"},{"key":"ref=6","year":"2017","unstructured":"Nigerian Tuberculosis Profile  population, 2017"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.21649\/akemu.v24i1.2309","volume":"24","author":"Tabassum M.N.","year":"2018","unstructured":"Tabassum M.N.; Khan M.A.; Afzal S.; Gilani S.A.; Gureja A.W.; Tabassum S.; Determination of Risk Factors among Multi-Drug Resistant Tuberculosis Patients. Annals of King Edward Medical University 2018,24,787-796","journal-title":"Annals of King Edward Medical University"},{"key":"ref=8","author":"Manaswini J","year":"2018","unstructured":"Manaswini J; Surya N.R; Avinash S.;  In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis 2018","journal-title":"In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/AEM.20.5.810-814.1970","volume":"20","author":"David H.L.","year":"1970","unstructured":"David H.L.; Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol 1970,20(5),810-814","journal-title":"Appl Microbiol"},{"key":"ref=10","author":"Mohammed H.B.","year":"2017","unstructured":"Mohammed H.B.; Faheem M.I.; Maqbool I.A.D.; Hafiz M.S.I.; Advances in the Treatment Options Towards Drug-Resistant Tuberculosis ISI Thomson -. Int J Pharmacol 2017","journal-title":"Int J Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1183\/09031936.00125711","volume":"39","author":"van der Werf M.J.","year":"2012","unstructured":"van der Werf M.J.; Langendam M.W.; Huitric E.; Manissero D.; Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis. Eur Respir J 2012,39(6),1511-1519","journal-title":"Eur Respir J"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148041","volume":"11","author":"Duan Q.","year":"2016","unstructured":"Duan Q.; Chen Z.; Chen C.; Zhang Z.; Lu Z.; Yang Y.; Zhang L.; The Prevalence of drug resistant tuberculosis in mainland China:an updated systematic review and meta-analysis. PLoS One 2016,11(2)","journal-title":"PLoS One"},{"key":"ref=13","year":"2015","unstructured":"World Health Organization Guidelines for surveillance of drug resistance in tuberculosis 2015","journal-title":"World Health Organization Guidelines for surveillance of drug resistance in tuberculosis"},{"key":"ref=14","year":"2017","unstructured":"world health organization; who. global tuberculosis report. 2017"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2017\/8340746","volume":"8340746","author":"Solima M.A.","year":"2017","unstructured":"Solima M.A.; Sabeel, Mohamed Ahmed Salih, ManasikAli, Salah-Eldin EL-Zaki, Nadir Abuzeid, Zeinab Abubaker Mohammed Elgadi, Hisham N. Altayb, Asrar M. A. Elegail, Nuha Y. Ibrahim, and Bahaeldin K. Elamin Phenotypic and Genotypic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Isolates from Sudanese Patients. Tuberc Res Treat 2017,8340746,6","journal-title":"Tuberc Res Treat"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"S1110","DOI":"10.1093\/infdis\/jir448","volume":"204","author":"David A.J.","year":"2011","unstructured":"David A.J.; Moore N.; Sarita Shah. Alternative methods of diagnosing drug resistance\u2014what can they do for me? J Infect Dis 2011,204,S1110-S1119","journal-title":"J Infect Dis"},{"key":"ref=17","year":"2016","unstructured":"World Health Organisation Global Tuberculosis Control: WHO report 2016 2016","journal-title":"World Health Organisation Global Tuberculosis Control: WHO report 2016"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4103\/0970-2113.159561","volume":"32","author":"Kalo D.","year":"2015","unstructured":"Kalo D.; Kant S.; Srivastava K.; Sharma A.K.; Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases. Lung India 2015,32(4),339-341","journal-title":"Lung India"},{"key":"ref=19","year":"2010","unstructured":"World Health Organization 2010","journal-title":"World Health Organization"},{"key":"ref=20","first-page":"5","volume":"1","year":"2019","unstructured":"WHO Technical Guide on NGS for DR-TB Christopher Gilpin. WEBINAR 2019,1,5","journal-title":"WEBINAR"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1128\/JCM.01958-12","volume":"50","author":"Barnard M. N.C.","year":"2012","unstructured":"Barnard M. N.C.; Gey van Pittius P. D.; van Helden M.; Bosman ; Coetzee R.M.W.; The Diagnostic Performance of the GenoTypeMTBDRplus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB\/RIF Assay. J Clin Microbiol 2012,50,3712-3716","journal-title":"J Clin Microbiol"},{"key":"ref=22","first-page":"21","volume":"41","author":"Canetti G.","year":"1969","unstructured":"Canetti G.; Fox W.; Khomenko A.; Mahler H.T.; Menon N.K.; Mitchison D.A.; Rist N.; Smelev N.A.; Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969,41(1),21-43","journal-title":"Bull World Health Organ"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3923\/jas.2007.933.935","volume":"7","author":"Umeh E.U.","year":"2007","unstructured":"Umeh E.U.; Ishaleku D.; Hieukwuemere C.C.; HIV\/TB coinfection among patients attending a referral chest clinic in Nasarawa State, Nigeria. J Appl Sci (Faisalabad) 2007,7,933-935","journal-title":"J Appl Sci (Faisalabad)"},{"key":"ref=24","first-page":"130","volume":"5","author":"Mary E.K.","year":"2016","unstructured":"Mary E.K.; Jonah B.O.; Ekerette E.E.; UdemeIta U. Prevalence of tuberculosis in Calabar, Nigeria: A case study of patients attending the outpatients Department of Dr. Lawrence Henshaw Memorial Hospital, Calabar: Saudi. J Health Sci 2016,5,130-133","journal-title":"J Health Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3923\/aje.2009.13.19","volume":"2","author":"Nwachukwu N.C.","year":"2009","unstructured":"Nwachukwu N.C.; Orji A.; Kanu I.; Okereke H.C.; Epidemiology of pulmonary tuberculosis in some parts of Abia State, Federal Republic of Nigeria. Asian J Epidemiol 2009,2,13-19","journal-title":"Asian J Epidemiol"},{"key":"ref=26","first-page":"10","volume":"1","author":"Imam T.S.","year":"2008","unstructured":"Imam T.S.; Oyeyi T.I.; A retrospective study of pulmonary tuberculosis (PTB)prevalence amongst patients attending Infectious Diseases Hospital (IDH) in Kano, Nigeria. Bayero J Pure Appl Sci 2008,1,10-15","journal-title":"Bayero J Pure Appl Sci"},{"key":"ref=27","first-page":"1904","volume":"4","author":"Onubogu C.C.","year":"2010","unstructured":"Onubogu C.C.; Kunle-Ope C.N.; Onyejepu N.; Nwokoye N.N.; Raheem T.Y.; Igbasi U.T.; Tochukwu N.E.; Omoloye R.M.; Ejezie C.O.; Musa A.Z.; Odunukwe N.N.; Onwujekwe D.I.; Idigbe E.O.; Prevalence of tuberculosis and human immunodeficiency virus (TB\/HIV) co-infections amongst patients with bronchopulmonary disorders in Lagos. Afr J Microbiol Res 2010,4,1904-1908","journal-title":"Afr J Microbiol Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40794-018-0065-5","volume":"4","author":"Girum T.","year":"2018","unstructured":"Girum T.; Muktar E.; Lentiro K.; Wondiye H.; Shewangizaw M.; Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines 2018,4,5","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3201\/eid1411.080729","volume":"14","author":"Eker B.","year":"2008","unstructured":"Eker B.; Ortmann J.; Migliori G.B.; Sotgiu G.; Muetterlein R.; Centis R.; Hoffmann H.; Kirsten D.; Schaberg T.; Ruesch-Gerdes S.; Lange C.; German TBNET Group Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 2008,14(11),1700-1706","journal-title":"Emerg Infect Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"a944","DOI":"10.4102\/ajlm.v7i2.805","volume":"7","author":"Otokunefor K.","year":"2018","unstructured":"Otokunefor K.; Otokunefor, TV; Omakwele G. Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria. Afr J Lab Med 2018,7,a944","journal-title":"Afr J Lab Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4172\/2161-0703.1000141","volume":"3","author":"Uzoewulu N.G.","year":"2014","unstructured":"Uzoewulu N.G.; Ibeh I.N.; Lawson L.; Goyal M.; Umenyonu N.; Drug resistant Mycobacterium tuberculosis in Tertiary Hospital South East, Nigeria. J Med Microb Diagn 2014,3,141","journal-title":"J Med Microb Diagn"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.11604\/pamj.2018.29.204.14579.","volume":"29","author":"Ebuenyi I.D.","year":"2018","unstructured":"Ebuenyi I.D.; Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. Pan Afr Med J 2018,29,204","journal-title":"Pan Afr Med J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","volume":"359","author":"Badri M.","year":"2002","unstructured":"Badri M.; Wilson D.; Wood R.; Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study. Lancet 2002,359(9323),2059-2064","journal-title":"Lancet"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2180-10-195","volume":"10","author":"Viegas S.O.","year":"2010","unstructured":"Viegas S.O.; Machado A.; Groenheit R.; Ghebremichael S.; Pennhag A.; Gudo P.S.; Cuna Z.; Miotto P.; Hill V.; Marrufo T.; Cirillo D.M.; Rastogi N.; K\u00e4llenius G.; Koivula T.; Molecular diversity of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mozambique. BMC Microbiol 2010,10,195","journal-title":"BMC Microbiol"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/235190","author":"Otu A.","year":"2013","unstructured":"Otu A.; Umoh V.; Habib A.; Ameh S.; Lawson L.; Ansa V.; Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria. Pulm Med 2013","journal-title":"Pulm Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/1596-3519.68355","volume":"9","author":"Lawson L.","year":"2010","unstructured":"Lawson L.; Habib A.G.; Okobi M.I.; Idiong D.; Olajide I.; Emenyonu N.; Onuoha N.; Cuevas L.E.; Ogiri S.O.;  Pilot study on multidrug resistant tuberculosis in Nigeria ann afr med 2010,9(3),184-187","journal-title":"Pilot study on multidrug resistant tuberculosis in Nigeria ann afr med"},{"key":"ref=37","first-page":"235","volume":"121","author":"Pereira M.","year":"2005","unstructured":"Pereira M.; Tripathy S.; Inamdar V.; Ramesh K.; Bhavsar M.; Date A.; Iyyer R.; Acchammachary A.; Mehendale S.; Risbud A.; Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res 2005,121(4),235-239","journal-title":"Indian J Med Res"},{"key":"ref=38","first-page":"220","volume":"1","author":"Anastasis D.","year":"1997","unstructured":"Anastasis D.; Pillai G.; Rambiritch V.; Abdool Karim S.S.; A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 1997,1(3),220-224","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=39","first-page":"903","volume":"87","author":"Post F.A.","year":"1997","unstructured":"Post F.A.; Wood R.; HIV infection is not associated with an increased rate of drug-resistant tuberculosis. S Afr Med J 1997,87(7),903","journal-title":"S Afr Med J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1128\/JCM.22.6.919-923.1985","volume":"22","author":"Siddiqi S.H.","year":"1985","unstructured":"Siddiqi S.H.; Hawkins J.E.; Laszlo A.; Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol 1985,22(6),919-923","journal-title":"J Clin Microbiol"},{"key":"ref=41","year":"2002","unstructured":"World Health Organization Gender and Tuberculosis, fact sheet 2002","journal-title":"World Health Organization Gender and Tuberculosis, fact sheet"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1365-3156.2011.02792.x","volume":"16","author":"Lawson L.","year":"2011","unstructured":"Lawson L.; Yassin M.A.; Abdurrahman S.T.; Parry C.M.; Dacombe R.; Sogaolu O.M.; Ebisike J.N.; Uzoewulu G.N.; Lawson L.O.; Emenyonu N.; Ouoha J.O.; David J.S.; Davies P.D.; Cuevas L.E.; Resistance to first-line tuberculosis drugs in three cities of Nigeria. Trop Med Int Health 2011,16(8),974-980","journal-title":"Trop Med Int Health"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105214","volume":"9","author":"Rifat M.","year":"2014","unstructured":"Rifat M.; Milton A.H.; Hall J.; Oldmeadow C.; Islam M.A.; Husain A.; Akhanda M.W.; Siddiquea B.N.; Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors. PLoS One 2014,9(8)","journal-title":"PLoS One"},{"key":"ref=44","first-page":"1065","volume":"12","author":"Law W.S.","year":"2008","unstructured":"Law W.S.; Yew W.W.; Chiu Leung C.; Kam K.M.; Tam C.M.; Chan C.K.; Leung C.C.; Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2008,12(9),1065-1070","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/cid\/cix561","volume":"65","author":"Smith S.E.","year":"2017","unstructured":"Smith S.E.; Pratt R.; Trieu L.; Barry P.M.; Thai D.T.; Ahuja S.D.; Shah S.; Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014. Clin Infect Dis 2017,65(9),1437-1443","journal-title":"Clin Infect Dis"},{"key":"ref=46","first-page":"756","volume":"12","author":"Dubrovina I.","year":"2008","unstructured":"Dubrovina I.; Miskinis K.; Lyepshina S.; Yann Y.; Hoffmann H.; Zaleskis R.; Nunn P.; Zignol M.; Drug-resistant tuberculosis and HIV in Ukraine: A threatening convergence of two epidemics? Int J Tuberc Lung Dis 2008,12(7),756-762","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/179750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T14:42:49Z","timestamp":1607697769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/179750\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201021666200226100242","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}